- Previous Close
0.0000 - Open
1.8600 - Bid 1.5200 x 306100
- Ask 2.3200 x 381200
- Day's Range
1.8600 - 1.8600 - 52 Week Range
1.4100 - 3.4500 - Volume
100 - Avg. Volume
85 - Market Cap (intraday)
243.824M - Beta (5Y Monthly) 1.54
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4500 - Earnings Date Feb 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
www.avitamedical.comRecent News: AVHHL
View MorePerformance Overview: AVHHL
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVHHL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVHHL
View MoreValuation Measures
Market Cap
233.86M
Enterprise Value
235.08M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.98
Price/Book (mrq)
19.94
Enterprise Value/Revenue
3.92
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-95.47%
Return on Assets (ttm)
-45.37%
Return on Equity (ttm)
-152.44%
Revenue (ttm)
60.04M
Net Income Avi to Common (ttm)
-57.32M
Diluted EPS (ttm)
-0.4500
Balance Sheet and Cash Flow
Total Cash (mrq)
44.41M
Total Debt/Equity (mrq)
373.16%
Levered Free Cash Flow (ttm)
-33.68M